|
Market Closed -
Bombay S.E.
14:02:33 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 31.00 INR | -3.12% |
|
+0.75% | -8.69% |
| Market Cap | 1.47B 15.26M 13.56M 12.65M 11.53M 21.75M 21.95M 153M 59.33M 750M 57.28M 56.04M 2.41B | P/E 2025 |
20.9x | P/E 2026 | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 1.81B 18.84M 16.74M 15.63M 14.24M 26.86M 27.11M 189M 73.28M 926M 70.74M 69.21M 2.97B | EV / Sales 2025 |
2.02x | EV / Sales 2026 | 1.27x |
| Free-Float |
9.04% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -3.13% | ||
| 1 week | +0.75% | ||
| Current month | -3.12% | ||
| 1 month | +7.56% | ||
| 3 months | -2.85% | ||
| 6 months | +15.76% | ||
| Current year | -8.69% |
| 1 week | 29.51 |  | 32.81 |
| 1 month | 25.51 | | 32.81 |
| Current year | 23.2 | | 43.28 |
| 1 year | 23.2 | | 43.28 |
| 3 years | 23.2 | | 86.85 |
| 5 years | 23.2 | | 86.85 |
| 10 years | 9.97 | | 86.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sameer Goel
CEO | Chief Executive Officer | 51 | 29/03/2016 |
Mani Jain
DFI | Director of Finance/CFO | - | 27/04/2026 |
| Compliance Officer | 46 | 27/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Sameer Goel
CHM | Chairman | 51 | 29/03/2016 |
Avinash Prabhat
BRD | Director/Board Member | 30 | 04/04/2026 |
Reema Goyal
BRD | Director/Board Member | 31 | 04/04/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.12% | +0.75% | -12.48% | -16.08% | 15.26M | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.52% | -2.24% | +23.21% | +49.83% | 369.72B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.52% | +68.96% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.19B 12.37M 10.99M 10.26M 9.35M 17.63M 17.8M 124M 48.11M 608M 46.44M 45.44M 1.95B | 1.15B 11.95M 10.62M 9.91M 9.03M 17.04M 17.19M 120M 46.47M 587M 44.87M 43.89M 1.88B |
| Net income | 96.12M 1M 888K 829K 756K 1.43M 1.44M 10.03M 3.89M 49.14M 3.75M 3.67M 158M | 74.34M 773K 687K 641K 584K 1.1M 1.11M 7.76M 3.01M 38M 2.9M 2.84M 122M |
| Net Debt | 392M 4.07M 3.62M 3.38M 3.08M 5.81M 5.86M 40.87M 15.84M 200M 15.29M 14.96M 642M | 345M 3.59M 3.19M 2.97M 2.71M 5.11M 5.16M 35.98M 13.94M 176M 13.46M 13.17M 566M |
Employees
205
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | ₹31.00 | -3.12% | 6,073 |
| 30/09/26 | ₹32.00 | +0.06% | 2,507 |
| 29/09/26 | ₹31.98 | +1.69% | 2,242 |
| 28/09/26 | ₹31.45 | +2.21% | 3,261 |
| 25/09/26 | ₹30.77 | +7.32% | 5,804 |
- Stock Market
- Stocks
- KIMIABL Stock
Select your edition
All financial news and data tailored to specific country editions
